Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-20 Purchase | 2023-07-24 4:40 pm | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 416,666 | $12 | $4,999,992 | 3,099,265 (Indirect) | View |
| 2023-05-11 Sale | 2023-05-15 6:06 pm | Verona Pharma plc | VRNA | Gupta Rishi Director | 482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) | View |
| 2022-12-22 Sale | 2022-12-27 5:32 pm | Verona Pharma plc | VRNA | Gupta Rishi Director | 6,139,864 | $22.15 | $136,000,855 | 34,085,528 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award(A) | 2024-02-20 7:30 pm | N/A 2034-02-13 | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 23,364 | $0 | 23,364 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:50 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 16,835 | $0 | 16,835 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:40 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 25,540 | $0 | 25,540 (Direct) | View |
| 2023-07-20 Conversion | 2023-07-24 4:40 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 5,365,198 | $0 | 3,099,265 (Indirect) | View |
Ownership | 2023-07-20 9:51 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 0 | $0 | 2,682,599 (Indirect) | View |
| 2023-05-17 Exercise | 2023-05-19 4:12 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 2,125 | $4.28 | 8,951,463 (Indirect) | View |
| 2023-05-17 Exercise | 2023-05-19 4:12 pm | N/A 2032-06-01 | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 2,125 | $0 | 8,951,463 (Indirect) | View |
| 2023-04-28 Option Award | 2023-04-28 4:20 pm | N/A 2033-04-27 | Verona Pharma plc | VRNA | Gupta Rishi Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-04-06 8:18 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 27,567 | $0 | 27,567 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 9:53 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner | 7,899,572 | $0 | 288,114 (Indirect) | View |
| 2022-04-28 Option Award | 2022-04-29 4:45 pm | N/A 2032-04-27 | Verona Pharma plc | VRNA | Gupta Rishi Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-10 4:46 pm | N/A 2031-08-08 | Verona Pharma plc | VRNA | Gupta Rishi Director | 64,000 | $0 | 64,000 (Direct) | View |
Ownership | 2021-01-05 7:22 pm | N/A N/A | Verona Pharma plc | VRNA | Gupta Rishi Director 10% Owner | 0 | $0 | 42,093,331 (Indirect) | View |
Ownership | 2021-01-04 8:20 pm | N/A 2030-09-24 | Verona Pharma plc | VRNA | Gupta Rishi Director | 0 | $0 | 185,600 (Direct) | View |